Clinical nutrition and drug interactions.

A drug's plasma level, pharmacological effects or side effects, elimination, physicochemical properties or stability could be changed by interactions of drug-drug or drug-nutrition products in patients who receive enteral or parenteral nutritional support. As a result, patients might experience ineffective outcomes or unexpected effects of therapy (such as drug toxicity, embolism). Stability or incompatibility problems between parenteral nutrition admixtures and drugs might lead to alterations in expected therapeutic responses from drug and/or parenteral nutrition, occlusion in venous catheter or symptoms or mortality due to infusion of composed particles. Compatibilities between parenteral nutrition and drugs are not always guaranteed in clinical practice. Although the list of compatibility or incompatibilities of drugs are published for the use of clinicians in their practices, factors such as composition of parenteral nutrition admixture, drug concentration, contact time in catheter, temperature of the environment and exposure to light could change the status of compatibilities between drugs and nutrition admixtures. There could be substantial clinical changes occurring in the patient's nutritional status and pharmacological effects of drugs due to interactions between enteral nutrition and drugs. Drug toxicity and ineffective nutritional support might occur as a result of those predictable interactions. Although administration of drugs via feeding tube is a complex and problematic route for drug usage, it is possible to minimise the risk of tube occlusion, decreased effects of drug and drug toxicity by using an appropriate technique. Therefore, it is important to consider pharmacological dosage forms of drugs while administering drugs via a feeding tube. In conclusion, since the pharmacists are well-experienced and more knowledgeable professionals in drugs and drug usage compared to other healthcare providers, it is suggested that provision of information and drug counselling by pharmacists in terms of detection and prevention of problems (such as interactions, stability, incompatibility) related with enteral/parenteral nutrition and drugs are invaluable in clinical practice.

[1]  John M. Allen.  Vasoactive substances and their effects on nutrition in the critically ill patient. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[2]  Michael R. Cohen.  Safe practices for compounding of parenteral nutrition. , 2012, JPEN. Journal of parenteral and enteral nutrition.

[3]  S. Mühlebach,et al.  Practical handling of AIO admixtures – Guidelines on Parenteral Nutrition, Chapter 10 , 2009, German medical science : GMS e-journal.

[4]  M. Shearer.  Vitamin K in parenteral nutrition. , 2009, Gastroenterology.

[5]  J. Boullata.  Drug Administration Through an Enteral Feeding Tube , 2009, The American journal of nursing.

[6]  J. Fish,et al.  Recommendations for the use of medications with continuous enteral nutrition. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[7]  G. Maartens,et al.  Pitfalls of administering drugs via nasogastric tubes. , 2009, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[8]  Charles Mueller,et al.  Enteral nutrition practice recommendations. , 2009, JPEN. Journal of parenteral and enteral nutrition.

[9]  N. Williams.  Medication administration through enteral feeding tubes. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[10]  G. Hardy,et al.  Stability and compatibility of histamine H2-receptor antagonists in parenteral nutrition mixtures , 2007, Current opinion in clinical nutrition and metabolic care.

[11]  A. Madden.  Handbook of drug administration via enteral feeding tubes , 2007 .

[12]  M. Baker,et al.  Drug compatibility with new polyolefin infusion solution containers. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[13]  Rebecca White.  Handbook of Drug Administration Via Enteral Feeding Tubes , 2006 .

[14]  A. Bernard,et al.  Enteral nutrition and drug administration, interactions, and complications. , 2005, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[15]  C. Seifert,et al.  A nationwide survey of long-term care facilities to determine the characteristics of medication administration through enteral feeding catheters. , 2005, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[16]  D. Seidner,et al.  Definition of terms, style, and conventions used in A.S.P.E.N. guidelines and standards. , 2005, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[17]  L. Hadaway.  Administering parenteral nutrition with other I.V. drugs. , 2005, Nursing.

[18]  R. Barton,et al.  A Guide to Drug Therapy in Patients with Enteral Feeding Tubes: Dosage Form Selection and Administration Methods , 2004 .

[19]  Mary Ann Howland,et al.  Fatality from Administration of Labetalol and Crushed Extended-Release Nifedipine , 2003, The Annals of pharmacotherapy.

[20]  D. Macauley,et al.  The solution was the problem. , 2002, Clinical nutrition.

[21]  L. Chan.  Drug-nutrient interaction in clinical nutrition , 2002, Current opinion in clinical nutrition and metabolic care.

[22]  D. L. Gilbert,et al.  Compatibility of medications with 3-in-1 parenteral nutrition admixtures. , 1999, JPEN. Journal of parenteral and enteral nutrition.

[23]  C. Seifert,et al.  Administration of medications through enteral feeding catheters. , 1997, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[24]  R. Berardi,et al.  Intravenous histamine H2-receptor antagonists and parenteral nutrition: patterns of use. , 1995, American Journal of Health-System Pharmacy.

[25]  S. Charland,et al.  Review: The Effect of Parenteral Nutrition on Hepatic Cytochrome P-450 , 1994 .

[26]  Susan W. Miller,et al.  Stability of Drugs with Enteral Nutrient Formulas , 1990, DICP : the annals of pharmacotherapy.

[27]  L. Holtz,et al.  Compatibility of medications with enteral feedings. , 1987, JPEN. Journal of parenteral and enteral nutrition.

[28]  E. Altman,et al.  Compatibility of enteral products with commonly employed drug additives. , 1983, JPEN. Journal of parenteral and enteral nutrition.

[29]  Richard D. Urman,et al.  Moderate and Deep Sedation in Clinical Practice: Guidelines and standards , 2012 .

[30]  J. Mirtallo.  Drug–Nutrient Interactions in Patients Receiving Parenteral Nutrition , 2009 .

[31]  A. Ramé.  Parenteral Nutrition , 1973 .

[32]  G. Sacks,et al.  Drug-Nutrient Considerations in Patients Receiving Parenteral and Enteral Nutrition NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #19 , 2004 .

[33]  M. Naysmith,et al.  Managing drug therapy in patients receiving enteral and parenteral nutrition , 2004 .

[34]  D. Min.  Handbook of Drug-Nutrient Interactions , 2004, Nutrition and Health.

[35]  K. Kudsk,et al.  Enteral nutrition , 2019, Therapeutic Gastrointestinal Endoscopy A problem-oriented approach.

[36]  S. Charland,et al.  The effect of parenteral nutrition on hepatic cytochrome P-450. , 1994, JPEN. Journal of parenteral and enteral nutrition.

[37]  Joseph T. DiPiro,et al.  Pharmacotherapy: A pathophysiologic approach , 1992 .

[38]  J. C. King,et al.  Compatibility and stability of electrolytes, vitamins and antibiotics in combination with 8% amino acids solution. , 1978, American journal of hospital pharmacy.